Command Palette

Search for a command to run...

QMSMEDI
109(+2.93%)
1W: +16.89%

Financials

Charts

YoY Net Sales
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Revenue growth has shown a consistent upward trend, indicating strong demand in the medical manufacturing sector.
  • Gross margins have improved, suggesting better cost management and pricing strategies.
  • The company has diversified its product range, enhancing its market positioning and revenue streams.
NEGATIVES
  • Net profit margins have contracted slightly, raising concerns about overall profitability amidst rising costs.
  • Operational inefficiencies have been noted, potentially hindering growth in the long term.
  • Market competition has intensified, putting pressure on pricing and market share.

Quarterly Results Data

FieldTrendSep 24Dec 24Mar 25Jun 25
Revenue
37.2043.8744.5846.49
Expenses
31.8639.0940.9842.33
Operating Profit
5.344.773.614.16
Other Income
0.330.191.090.32
Interest
1.071.311.411.42
Depreciation
0.840.861.360.86
Profit Before Tax
5.664.964.704.48
Tax
1.431.501.091.33
Net Profit
4.233.463.613.15
Eps in Rs
1.931.631.871.64